Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Burkitt Lymphoma 23Multiple Myeloma 21Lymphoma, Large B-Cell, Diffuse 21Leukemia, Myeloid, Acute 18Lymphoma, Non-Hodgkin 16Myelodysplastic Syndromes 15Lymphoma, B-Cell 14Lymphoma 14Recurrence 11Ovarian Neoplasms 11Lymphoma, Follicular 11Hodgkin Disease 11Triple Negative Breast Neoplasms 10Neoplasms 9Lymphoma, Mantle-Cell 9Leukemia, Lymphocytic, Chronic, B-Cell 9Breast Neoplasms 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Pancreatic Neoplasms 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia 8Hematologic Neoplasms 7Sarcoma 6Osteosarcoma 6Leukemia, Myelomonocytic, Chronic 6Colorectal Neoplasms 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Biphenotypic, Acute 5Graft vs Host Disease 5

Interventions

Rituximab 2pomalidomide 1dehydroftorafur 1Watchful Waiting 1Vincristine 1Taxes 1Radiotherapy, Intensity-Modulated 1Prednisone 1Platinum 1Paclitaxel 1Nivolumab 1Gemcitabine 1Fluorouracil 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Epstein-Barr Virus Infections × Cyclophosphamide × 30 days × Clear all
NCT05389423 2026-06-01

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
25 enrolled
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡